Sign in

CIK 0001789972 · Non-accelerated filer<br>Smaller reporting company

Cullinan Therapeutics, Inc.

Sign in to watch
Ticker
CGEM
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
813879991
Phone
617-410-4650
Business address
ONE MAIN STREET, SUITE 1350, CAMBRIDGE, MA, 02142
Former names
Cullinan Oncology, Inc., Cullinan Management, Inc., Cullinan Oncology, LLC
  1. 8-K Event Material agreement · Acquisition or sale completed · Regulation FD disclosure
  2. 8-K Event Shareholder vote results
  3. 4 Open-market sale 10% owner sold 101,903 shares at an average $12.80 ($1,304,816)
  4. 4 Derivatives Options or other derivatives
  5. 4 Derivatives Options or other derivatives
  6. 4 Derivatives Options or other derivatives
  7. 4 Derivatives Options or other derivatives
  8. 4 Open-market buy President and CEO bought 8,090 shares at $12.40 ($100,316)
  9. 4 Open-market buy 10% owner bought 751,396 shares at $11.00 ($8,264,905)
  10. 4 Open-market sale 10% owner sold 418,738 shares at an average $9.66 ($4,045,791)
  11. 4 Open-market buy 10% owner bought 1,109,900 shares at an average $9.07 ($10,063,937)
  12. 10-Q Report Quarterly Report
  13. 8-K Event Results of operations
  14. 8-K Event Material agreement · Results of operations · Regulation FD disclosure
  15. DEFA14A Proxy Proxy Materials
  16. DEF 14A Proxy Proxy Statement
  17. 4 Open-market buy 10% owner bought 276,000 shares at $10.75 ($2,966,972)
  18. 4 Derivatives Options or other derivatives
  19. 4 Derivatives Options or other derivatives
  20. 4 Derivatives Options or other derivatives

Page 17 of 24 · 471 filings